A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

It needs to take Ozempic. As president, Joe Biden unilaterally expanded wasteful spending in government health programs. On his first day back in the White House, Donald Trump revoked two Biden ...

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and Wegovy ... “This review was not conducted in any way that we can ...

Sweeping review suggests weight-loss drugs’ effect on 175 conditions - The Washington Post End of the Line for BMI? Experts Propose New Obesity Definition - Newsweek Most people quit Ozempic ...

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

If you have ditched the diet only to see the weight creep on at an alarming rate, your body may have a high metabolic set point, meaning you will always put on the pounds faster than others. Serial di ...

Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine ...

A San Francisco online health company that recently faced local backlash over its donation to President Donald Trump’s inauguration is now in hot water over a Super Bowl ad. Hims & Hers, a telehealth ...

There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.